BNP Paribas Financial Markets’s BioAtla BCAB Stock Holding History

BNP Paribas Financial Markets’s Portfolio BCAB Stock Details BCAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$29	Sell	7 -2	-22%	-$8	﹤0.01%	5844
2026 Q1	$76	Hold	9	–	–	﹤0.01%	5697
2025 Q4	$268	Hold	9	–	–	﹤0.01%	5541
2025 Q3	$325	Hold	9	–	–	﹤0.01%	5342
2025 Q2	$187	Hold	9	–	–	﹤0.01%	5288
2025 Q1	$164	Sell	9 -8	-47%	-$171	﹤0.01%	5225
2024 Q4	$507	Buy	+17	New	+$1.43K	﹤0.01%	5169
2022 Q4	–	Sell	-326	Closed	-$125K	–	4104
2022 Q3	$125K	Buy	+326	New	+$107K	﹤0.01%	3679

Other funds holding BCAB

Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

BNP Paribas Financial Markets's BCAB Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its BioAtla (BCAB) stake by 22% in Q2 2026, selling an estimated $8 and leaving 7 shares worth $29. The position accounts for ﹤0.01% of the portfolio, ranked #5844.

BNP Paribas Financial Markets first reported a position in BCAB in Q3 2022 and has held it in 8 quarters since. The position peaked at $125K in Q3 2022. 15 funds tracked by Wall St. Rank hold BCAB as of Q2 2026.

BNP Paribas Financial Markets held 7 shares of BioAtla worth $29 as of Q2 2026.
BNP Paribas Financial Markets sold 2 BioAtla shares in Q2 2026, an estimated $8.
BioAtla made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5844 holding.
BNP Paribas Financial Markets first reported a position in BioAtla in Q3 2022 and has held it in 8 quarters since.
BNP Paribas Financial Markets's BioAtla position peaked at $125K in Q3 2022.
15 funds tracked by Wall St. Rank held BioAtla as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.